Adell Harriman & Carpenter Inc. Has $3.53 Million Stake in Danaher Co. (NYSE:DHR)

Adell Harriman & Carpenter Inc. decreased its holdings in shares of Danaher Co. (NYSE:DHR) by 4.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 15,368 shares of the conglomerate’s stock after selling 755 shares during the quarter. Adell Harriman & Carpenter Inc.’s holdings in Danaher were worth $3,528,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of DHR. AMF Tjanstepension AB bought a new stake in shares of Danaher during the third quarter worth about $5,923,000. Wedge Capital Management L L P NC grew its holdings in shares of Danaher by 3.2% during the third quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate’s stock worth $342,000 after purchasing an additional 38 shares during the last quarter. Creative Planning grew its holdings in shares of Danaher by 3.1% during the third quarter. Creative Planning now owns 126,340 shares of the conglomerate’s stock worth $35,125,000 after purchasing an additional 3,749 shares during the last quarter. Probity Advisors Inc. bought a new stake in shares of Danaher during the third quarter worth about $221,000. Finally, Good Life Advisors LLC bought a new stake in shares of Danaher during the third quarter worth about $217,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

DHR has been the topic of several analyst reports. UBS Group reduced their target price on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. TD Cowen upped their target price on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Raymond James reiterated a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. Royal Bank of Canada reiterated an “outperform” rating and issued a $277.00 target price (down from $299.00) on shares of Danaher in a report on Thursday, January 30th. Finally, Jefferies Financial Group reduced their target price on Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a report on Wednesday, January 29th. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average price target of $278.00.

Insider Activity at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 11.10% of the stock is currently owned by insiders.

Danaher Price Performance

Shares of NYSE:DHR opened at $206.66 on Friday. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The stock’s 50 day moving average is $230.00 and its 200-day moving average is $249.96. The firm has a market capitalization of $149.26 billion, a price-to-earnings ratio of 39.14, a PEG ratio of 2.68 and a beta of 0.83.

Danaher (NYSE:DHR) last issued its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the business earned $2.09 EPS. Sell-side analysts forecast that Danaher Co. will post 7.67 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.52%. The ex-dividend date was Friday, December 27th. Danaher’s payout ratio is currently 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.